Surgery Partners (SGRY) Depreciation & Amortization (CF) (2014 - 2026)

Surgery Partners' Depreciation & Amortization (CF) history runs 13 years deep, the most recent figure standing at $38.5 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 6.06% year-over-year to $38.5 million; the TTM figure through Mar 2026 stood at $178.2 million (up 14.82% YoY), while the FY2025 annual figure was $176.0 million, up 15.33% from the prior year.
• Depreciation & Amortization (CF) came in at $38.5 million for Q1 2026 at Surgery Partners, down from $59.9 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $59.9 million in Q4 2025 to a low of $24.4 million in Q2 2023.
• A 5-year average of $35.3 million and a median of $33.7 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• On a YoY basis, Depreciation & Amortization (CF) climbed as much as 76.7% in 2025 and fell as far as 21.31% in 2025.
• Surgery Partners' Depreciation & Amortization (CF) stood at $29.6 million in 2022, then gained by 5.07% to $31.1 million in 2023, then rose by 9.0% to $33.9 million in 2024, then jumped by 76.7% to $59.9 million in 2025, then plunged by 35.73% to $38.5 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $38.5 million, $59.9 million, and $39.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison